Anti-Glycolytic Drugs in the Treatment of Hepatocellular Carcinoma: Systemic and Locoregional Options

Hepatocellular cancer (HCC) is the most common primary liver cancer and the third leading cause of cancer-related death. Locoregional therapies, including transarterial embolization (TAE: bland embolization), chemoembolization (TACE), and radioembolization, have demonstrated survival benefits when t...

Descripción completa

Detalles Bibliográficos
Autores principales: Pourbaghi, Miles, Haghani, Leila, Zhao, Ken, Karimi, Anita, Marinelli, Brett, Erinjeri, Joseph P., Geschwind, Jean-Francois H., Yarmohammadi, Hooman
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10377758/
https://www.ncbi.nlm.nih.gov/pubmed/37504345
http://dx.doi.org/10.3390/curroncol30070485

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10377758/
https://www.ncbi.nlm.nih.gov/pubmed/37504345
http://dx.doi.org/10.3390/curroncol30070485

Ejemplares similares